EP0773975A4 - Conducting electroactive biomaterials - Google Patents

Conducting electroactive biomaterials

Info

Publication number
EP0773975A4
EP0773975A4 EP95926798A EP95926798A EP0773975A4 EP 0773975 A4 EP0773975 A4 EP 0773975A4 EP 95926798 A EP95926798 A EP 95926798A EP 95926798 A EP95926798 A EP 95926798A EP 0773975 A4 EP0773975 A4 EP 0773975A4
Authority
EP
European Patent Office
Prior art keywords
biomaterials
electroactive
conducting
conducting electroactive
electroactive biomaterials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95926798A
Other languages
German (de)
French (fr)
Other versions
EP0773975A1 (en
Inventor
Gordon George Wallace
Anthony Joseph Hodgson
Toni Elizabeth Campbell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPM7265A external-priority patent/AUPM726594A0/en
Priority claimed from AUPN2116A external-priority patent/AUPN211695A0/en
Application filed by Individual filed Critical Individual
Publication of EP0773975A1 publication Critical patent/EP0773975A1/en
Publication of EP0773975A4 publication Critical patent/EP0773975A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • G01N33/556—Fixed or stabilised red blood cell
EP95926798A 1994-08-04 1995-08-04 Conducting electroactive biomaterials Withdrawn EP0773975A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPM7265A AUPM726594A0 (en) 1994-08-04 1994-08-04 Conducting electroactive biomaterials
AUPM7265/94 1994-08-04
AUPN2116A AUPN211695A0 (en) 1995-03-31 1995-03-31 Cytopolymer
AUPN2116/95 1995-03-31
PCT/AU1995/000473 WO1996004340A1 (en) 1994-08-04 1995-08-04 Conducting electroactive biomaterials

Publications (2)

Publication Number Publication Date
EP0773975A1 EP0773975A1 (en) 1997-05-21
EP0773975A4 true EP0773975A4 (en) 1998-06-10

Family

ID=25644730

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95926798A Withdrawn EP0773975A4 (en) 1994-08-04 1995-08-04 Conducting electroactive biomaterials

Country Status (2)

Country Link
EP (1) EP0773975A4 (en)
WO (1) WO1996004340A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020043A1 (en) 1996-11-08 1998-05-14 Morphogenesis, Inc. Materials and procedures for the purification of cells
ITPD20010108A1 (en) 2001-05-08 2002-11-08 Fidia Advanced Biopolymers Srl ELECTRICALLY CONDUCTIVE POLYMERIC BIOMATERIALS, THEIR PROCESS OF PREPARATION AND USE IN THE HEALTH BIOMEDICAL SECTOR.
WO2016196604A1 (en) 2015-06-04 2016-12-08 The University Of Florida Research Foundation, Inc. Electroactive supramolecular polymeric assemblies, methods of making electroactive supramolecular polymeric assemblies, and methods of using electroactive supramolecular polymeric assemblies
WO2023004171A1 (en) * 2021-07-23 2023-01-26 The Regents Of The University Of California Electrically fueled active supramolecular materials, and applications thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3607302A1 (en) * 1986-03-06 1987-09-10 Basf Ag Method of producing electrically conductive polymers
JPH0220586A (en) * 1988-07-08 1990-01-24 Komatsu Ltd Mechanochemical material
EP0454044A2 (en) * 1990-04-25 1991-10-30 Hoechst Aktiengesellschaft Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
JPH04253744A (en) * 1991-02-04 1992-09-09 Showa Denko Kk Conductive polymeric material and its production
EP0627747A1 (en) * 1993-06-03 1994-12-07 Commissariat A L'energie Atomique Conductive polymer doped with sulfonated cyclodextrine salt and device for capturing and/or delivering an active substance using this polymer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU495261B2 (en) * 1974-09-18 1977-03-17 Pharmaceutical Society of Victoria and Peter Speiser Nanoparticles and method of preparing same
CS216992B1 (en) * 1980-07-21 1982-12-31 Miroslav Stol Composite polymere material for the biological and medicinal utilitation and method of preparation thereof
US4423099A (en) * 1980-07-28 1983-12-27 Ciba-Geigy Corporation Membrane modified hydrogels
FR2517315B1 (en) * 1981-11-30 1985-12-20 Tech Cuir Centre PROCESS FOR THE PREPARATION OF NEW FORMS OF COLLAGEN, NATIVE OR DERETICULATED, WITH PRESERVED HELICOIDAL STRUCTURE, ASSOCIATED WITH MUCOPOLYSACCHARIDES AND THEIR APPLICATIONS IN PARTICULAR IN THE COSMETOLOGICAL, PHARMACEUTICAL, ANALYTICAL AND OTHER FIELDS
US4585652A (en) * 1984-11-19 1986-04-29 Regents Of The University Of Minnesota Electrochemical controlled release drug delivery system
GB8430252D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
CA1341077C (en) * 1988-03-31 2000-08-08 Randell L. Mills Luminide and macroluminide class of pharmaceuticals
US5216130A (en) * 1990-05-17 1993-06-01 Albany Medical College Complex for in-vivo target localization
WO1992011844A1 (en) * 1991-01-03 1992-07-23 Alkermes Controlled Therapeutics, Inc. Stabilization of proteins by cationic biopolymers

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3607302A1 (en) * 1986-03-06 1987-09-10 Basf Ag Method of producing electrically conductive polymers
JPH0220586A (en) * 1988-07-08 1990-01-24 Komatsu Ltd Mechanochemical material
EP0454044A2 (en) * 1990-04-25 1991-10-30 Hoechst Aktiengesellschaft Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
JPH04253744A (en) * 1991-02-04 1992-09-09 Showa Denko Kk Conductive polymeric material and its production
EP0627747A1 (en) * 1993-06-03 1994-12-07 Commissariat A L'energie Atomique Conductive polymer doped with sulfonated cyclodextrine salt and device for capturing and/or delivering an active substance using this polymer

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 9010, Derwent World Patents Index; AN 69655 *
DATABASE WPI Week 9243, Derwent World Patents Index; AN 352672 *
PATENT ABSTRACTS OF JAPAN vol. 14, no. 149 (C - 705) 22 March 1990 (1990-03-22) *
PATENT ABSTRACTS OF JAPAN vol. 17, no. 37 (C - 1019) 25 January 1993 (1993-01-25) *
See also references of WO9604340A1 *

Also Published As

Publication number Publication date
WO1996004340A1 (en) 1996-02-15
EP0773975A1 (en) 1997-05-21

Similar Documents

Publication Publication Date Title
PL319266A1 (en) Terminal
EP0694903A3 (en) Receiving circuit
GB9423388D0 (en) Holesaw assembly
GB9406105D0 (en) Assembly
EP0703641A3 (en) Electrical connection member
EP0704942A3 (en) Electrical connection terminal-block
EP0773975A4 (en) Conducting electroactive biomaterials
GB2296371B (en) Cathode arrangements
ZA953003B (en) Connection arrangement
GB2292487B (en) Connection arrangement
GB2301695B (en) Sign
ZA9410233B (en) Electrical fitting
EP0763063A4 (en) Lysozyme-degradable biomaterials
AUPM726594A0 (en) Conducting electroactive biomaterials
GB9720888D0 (en) Tolerance
GB2286644A8 (en) Connection
EP0706238A3 (en) Connection arrangement
GB9413564D0 (en) Assembly
KR960009577U (en) Pcb
GB2309002B (en) Signs
GB9611732D0 (en) Adhesive electrical
GB2306797B (en) Electrical connection
KR0107674Y1 (en) Bulletin
AU121704S (en) Witch with cauldren planter
GB9418368D0 (en) Electrical arrangement

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970304

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19980422

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000301